Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 25, 2022

SELL
$43.66 - $61.0 $2.71 Million - $3.79 Million
-62,100 Reduced 50.7%
60,397 $3.25 Million
Q2 2022

Jul 22, 2022

SELL
$28.82 - $77.35 $11.8 Million - $31.6 Million
-409,093 Reduced 76.96%
122,497 $4.95 Million
Q1 2022

Apr 21, 2022

BUY
$48.25 - $100.49 $11.7 Million - $24.3 Million
242,223 Added 83.71%
531,590 $35.1 Million
Q4 2021

Feb 08, 2022

BUY
$88.71 - $120.43 $25.7 Million - $34.8 Million
289,367 New
289,367 $28.9 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.59B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Artemis Investment Management LLP Portfolio

Follow Artemis Investment Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artemis Investment Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Artemis Investment Management LLP with notifications on news.